Healthcare Archives - Page 2 of 15 - Boston Life Sciences Times

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

April 27, 2026

908 Devices Names Kola Otitoju Chief Business & Strategy Officer, Announces Inducement Grant

April 22, 2026

Bicycle Therapeutics Reports Promising Cancer Drug Data at AACR Meeting

April 20, 2026

THIS WEEK'S STORIES

AstraZeneca’s SAPHNELO Approved in U.S. as Self-Injectable Treatment for Lupus

April 27, 2026

Motif Neurotech Wins FDA Clearance to Launch First Human Trial for Depression Implant

April 27, 2026

Veristat to Acquire Certara’s Regulatory and Medical Writing Unit in Expansion Move

April 22, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Healthcare

Premier Study Unveils New Tool to Identify High-Risk Pregnancies Earlier

Cerus Signs Four-Year Supply Deal With French Blood Agency for INTERCEPT System

IVI RMA Clinics Earn National Recognition in Newsweek’s 2026 Fertility Rankings

Ultralight Raises $9.3 Million to Expand AI Platform for Personalized Medicine

Cognito Therapeutics to drop use of “dementia” in communications through new partnership

Most Read

Premier Study Unveils New Tool to Identify High-Risk Pregnancies Earlier

Cerus Signs Four-Year Supply Deal With French Blood Agency for INTERCEPT System

Veradermics Reports Strong Late-Stage Trial Results for Oral Hair Loss Treatment

VGM and Trace Medical Expand Partnership With Exclusive Nationwide Agreement

EDITOR PICKS

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

908 Devices Names Kola Otitoju Chief Business & Strategy Officer, Announces Inducement Grant

Bicycle Therapeutics Reports Promising Cancer Drug Data at AACR Meeting

THIS WEEK'S STORIES

AstraZeneca’s SAPHNELO Approved in U.S. as Self-Injectable Treatment for Lupus

Motif Neurotech Wins FDA Clearance to Launch First Human Trial for Depression Implant

Veristat to Acquire Certara’s Regulatory and Medical Writing Unit in Expansion Move

POPULAR CATEGORY

ABOUT US

FOLLOW US